Design of the archetypical first commercial peptide array for kinome profiling from 2003 (produced at that time by Pepscan Systems). The relative small and PKC/PKA biased peptide set precluded wide spread implementation. Its low costs, however, make this chip highly attractive for optimalisation of assay conditions for particular tissue types and for this purpose it is widely used to this day.
